Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LPI 15:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004466 AN007487 Differential mechanisms of membrane lipid disruption by antibiotic lipopeptides colistin and turnercyclamycins Bacterial cells Bacteria Bacterial infection University of Utah LC-MS
ST004204 AN006991 The growth and virulence of S. aureus is inhibited by C. striatum by inhibiting its arginine biosynthesis pathway Bacterial cells Staphylococcus aureus Chronic rhinosinusitis Sun Yat-sen University LC-MS
ST004138 AN006861 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Autoimmune disease Hangzhou Xixi Hospital LC-MS
ST004138 AN006861 Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus Feces Human Liver disease Hangzhou Xixi Hospital LC-MS
ST003817 AN006276 Irisin promotes bone tissue repair and intestinal protection in osteoporotic mice Feces Mouse Osteoporosis Huizhou Central People's Hospital LC-MS
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology LC-MS
  logo